21087 ⎘
Medicinal preparations containing antigens or antibodies; Bacterial antigens; Enterobacteriales, e.g. Enterobacter Salmonella
SHIGELLA MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION AND FUSION PROTEINS THEREOF
#2Pharmaceutical Composition, Preparation Method and Use Thereof
#3Methods for Vaccinating against Salmonella Species
#4INTRANASAL POLYSACCHARIDE CONJUGATE NANOMULSION VACCINES AND METHODS OF USING THE SAME
#5IMMUNOGENIC GEL COMPOSITIONS
#6ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF
#7SALMONELLA FREE EGG PRODUCTION METHODS AND SYSTEMS
#8THERMOSTABLE UV INACTIVATED VACCINES AND OTHER BIOPHARMACEUTICALS
#9PREPARATION OF LIVE VACCINES
#10SELF-ASSEMBLING PROTEIN NANOPARTICLES ENCAPSULATING IMMUNOSTIMULATORY NUCLEID ACIDS
#11IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF
#12A Novel Poultry Salmonella Vaccine and Diagnostic Methodology to Control Foodborne Salmonellosis
#13A MAPS VACCINE TARGETING SALMONELLA ENTERICA SEROVARS
#14CANCER THERAPY WITH LIVE ATTENUATED BACTERIA
#15COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER USING BACTERIA
#16METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTICMICROBIAL THERAPEUTICS
#17GUT BACTERIA DERIVED MICROVESICLES FOR VACCINE DELIVERY
#18Methods and compositions related to the next generation vaccine
#19MODIFIED BACTERIUM, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#20A BROADLY PROTECTIVE PROPHYLACTIC VACCINE AGAINST PSEUDOMONAS AERUGINOSA
#21Cancer therapy with live attenuated bacteria
#22ATTENUATED SALMONELLA GALLINARUM STRAIN AND USE THEREOF
#23SALMONELLA VACCINE
#24Personalized Site-Specific Immunomodulation
#25PREPARATION OF LIVE VACCINES
#26LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS HETEROLOGOUS OUTER MEMBRANE PROTEIN ANTIGENS AND METHODS OF USE THEREOF
#27Hyper-Blebbing Bacteria
#28SELF-ASSEMBLING PROTEIN NANOPARTICLES ENCAPSULATING IMMUNOSTIMULATORY NUCLEID ACIDS
#29VACCINES FOR THE TREATMENT AND PREVENTION OF SEASONAL AND EMERGING INFECTIONS
#30VACCINATION FOR PROTECTING POULTRY AGAINST A POULTRY PATHOGEN
#31IMMUNOGENIC COMPOSITIONS COMPRISING LAWSONIA INTRACELLULARIS
#32COMPOSITIONS AND METHODS RELATING TO TYPHOID TOXIN SUBUNIT PLTC
#33VACCINE AND THERAPEUTIC COMPOSITIONS COMPRISING ANTIGEN-CONJUGATED VIRAL CAPSIDS
#34IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF
#35IMMUNOGENIC GEL COMPOSITIONS
#36Use of the Salmonella SPP Type III Secretion Proteins as a Protective Vaccination
#37MULTI-SENSORY ENRICHMENT WITH SELF-ADMINISTERING HEALTH PRODUCT DELIVERY SYSTEM
#38LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS PROTEIN ANTIGENS AND METHODS OF USE THEREOF
#39IN OVO VACCINES IN COMBINATION WITH PROBIOTICS
#40Engineered immunostimulatory bacterial strains and uses thereof
#41ATTENUATED SALMONELLA GALLINARUM MUTANT STRAINS AND USES THEREOF
#42DOSAGE AND ADMINISTRATION OF A BACTERIAL SACCHARIDE GLYCOCONJUGATE VACCINE
#43ATTENUATED SALMONELLA GALLINARUM MUTANT STRAINS AND USES THEREOF
#44Vaccine delivery method
#45LIVE ATTENUATED ORAL VACCINE AGAINST SHIGELLOSIS AND TYPHOID FEVER
#46Engineered immunostimulatory bacterial strains and uses thereof
#47Novel PD-L1 Targeting DNA Vaccine for Cancer Immunotherapy
#48MODIFIED STRAIN OF SALMONELLA ENTERICA TYPHI
#49NEW IMMUNOGENIC COMPOSITIONS
#50Triple vaccine for diseases caused by and
#51COMPOSITION FOR MUCOSAL ADMINISTRATION TO AVIANS
#52Live Attenuated Non-Transmissible Vaccines
#53TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM
#54Gut bacteria derived microvesicles for vaccine delivery
#55Preparation of live vaccines
#56MULTIVALENT GLYCOCONJUGATES IMMUNOGENIC COMPOSITIONS
#57COMPOSITIONS FOR IMPROVING VACCINE SAFETY AND EFFICACY AND METHODS OF USE THEREOF
#58METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTIC MICROBIAL THERAPEUTICS
#59Method for preparing live attenuated vaccine by irradiation and live attenuated vaccine composition prepared by the same
#60Method For Preparation of Quick Dissolving Thin Films Containing Bioactive Material With Enhanced Thermal Stability
#61Induction of protective immunity against antigens
#62Food safety vaccine to control and reduce in poultry
#63ENGINEERED SALMONELLA SEROVAR TYPHIMURIUM STRAINS, COMPOSITIONS THEREOF, AND METHODS OF USE
#64Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMVS) for delivery to the GI-tract
#65Use of toll-like receptor agonist for treating cancer
#66METHOD OF REDUCING EGG CONTAMINATION
#67Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
#68FLAGELLIN RELATED POLYPEPTIDES AND USES THEREOF
#69Immunomodulating and immunostimulating ecotin polypeptides from for drug-delivery
#70Nanoparticle compositions for vaccines
#71Immunogenic compositions comprising
#72ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF
#73Vaccine delivery method
#74Mucosal adjuvants and delivery systems
#75Enteric fever vaccine based on outer membrane vesicles from two different strains of typhoidal species
#76Live attenuated oral vaccine against ETEC and typhoid fever
#77D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation
#78VACCINES AND METHODS OF VACCINATION AGAINST SCHISTOSOMA
#79Use of the salmonella SPP type III secretion proteins as a protective vaccination
#80Compositions and methods of enhancing immune responses to enteric pathogens
#81Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same
#82Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response
#83Vaccine and therapeutic compositions comprising antigen-conjugated viral capsids
#84Flagellin related polypeptides and uses thereof
#85Modified strain of Typhi
#86Immunogenic proteins against
#87Engineered immunostimulatory bacterial strains and uses thereof
#88Live vectors engineered to express heterologous outer membrane protein antigens and methods of use thereof
#89Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
#90Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers
#91Personalized Site-Specific Immunomodulation
#92VACCINE AND METHOD OF VACCINATION AGAINST CLOSTRIDIUM DIFFICILE USING A LIVE BACTERIAL VECTOR
#93PD-L1 targeting DNA vaccine for cancer immunotherapy
#94ALGAL BASED EDIBLE VACCINES
#95SELF-ASSEMBLING PROTEIN NANOPARTICLES ENCAPSULATING IMMUNOSTIMULATORY NUCLEID ACIDS
#96Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
#97Food safety vaccine to control and reduce campylobacter in poultry
#98Induction of protective immunity against antigens
#99Compositions and methods of enhancing immune responses to enteric pathogens
#100Mutated Salmonella Enterica
#101Use of toll-like receptor agonist for treating cancer
#102Mucosal adjuvants and delivery systems
#103Composition for oral delivery of bioactive agents
#104Method of reducing egg contamination
#105SALMONELLA VACCINES
#106COMPOSITION FOR DELIVERY OF ACTIVE AGENTS TO AN ANIMAL
#107Flagellin related polypeptides and uses thereof
#108CONJUGATE FOR VACCINATION AGAINST TYPHOID COMPRISING CHEMICAL CONJUGATE OF VI POLYSACCHARIDE AND FLAGELLIN, A PROCESS FOR PRODUCING THE SAME AND A COMPOSITION COMPRISING THE CONJUGATE
#109Immunogenic compositions comprising
#110Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMVs) for delivery to the GI-tract
#111Virulence attenuated bacteria for treatment of malignant solid tumors
#112Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
#113DNA vaccine for use in pancreatic cancer patients
#114Immunogenic compositions and uses thereof
#115Manufacture of vaccines and compositions for the prevention of infections
#116Vaccines and compositions for the prevention of infections
#117Immunogenic proteins against clostridium difficile
#118Use of toll-like receptor agonist for treating cancer
#119Methods for the prevention of infections
#120Methods for making saccharide-protein glycoconjugates
#121Method to enhance immunogenicity of live typhoid vaccines and carriers
#122Live attenuated oral vaccine against shigellosis and typhoid fever
#123A METHOD FOR CD4+ T-CELL EPITOPE PREDICTION USING ANTIGEN STRUCTURE
#124Use of the salmonella SPP type III secretion proteins as a protective vaccination
#125Polysaccharide vaccine formulations and processes for industrial production of bacterial polysaccharides
#126Chimeric proteins
#127COMPOSITION FOR DELIVERY OF ACTIVE AGENTS TO AN ANIMAL
#128Flagellin related polypeptides and uses thereof
#129Immune modulator for immunotherapy and vaccine formulation
#130Compositions and methods for producing bacterial conjugate vaccines
#131Mutated
#132with an O-antigen having an extended carbohydrate chain and use thereof
#133Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants)
#134Use of toll-like receptor agonist for treating cancer
#135Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers
#136ATTENUATED LIVE BACTERIA WITH INCREASED ACID RESISTANCE AND METHODS OF USE THEREOF
#137Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same
#138LPS vaccine
#139Vaccine for livestock production systems
#140Emulsified vaccine to obtain formulations of concentrated IgY immunoglobulins; processes and uses for the same
#141Vaccine adjuvant compositions
#142RECOMBINANT BACTERIUM AND METHODS OF ANTIGEN AND NUCLEIC ACID DELIVERY
#143Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
#144VACCINE DELIVERY METHOD
#145Dual adjuvant vaccine compositions, preparation and uses
#146Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject
#147Mucosal adjuvants and delivery systems
#148Synthetic derivatives of MPL and uses thereof
#149Immunizing compositions and methods of use
#150Compositions produced using enteric pathogens and methods of use
#151Compositions produced using enteric pathogens and methods of use
#152Compositions produced using enteric pathogens and methods of use
#153Flagellin related polypeptides and uses thereof
#154Method to introduce into ground meat
#155SALMONELLA CHOLERAESUIS-SALMONELLA TYPHIMURIUM VACCINES
#156Method of treating protozoal gastrointestinal disorders in immunocompromised patients
#157LIVE SALMONELLA VACCINE AND METHODS TO PREVENT FOWL TYPHOID
#158Compositions produced using enteric pathogens and methods of use
#159Compositions and methods for using toxin to induce or enhance an immune response
#160Mutated
#161Immunogenic compositions comprising
#162Algal based edible vaccines
#163Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens
#164Methods for making saccharide-protein glycoconjugates
#165Composition for oral delivery of bioactive agents
#166Salmonella conjugate vaccines
#167Tissue targeted antigenic activation of the immune response to treat cancers
#168LPS VACCINE
#169Use of the SPP type III secretion proteins as a protective vaccination
#170Methods of using presenting N-glycan or derivatives thereof
#171Bacterial vaccine and methods for manufacture thereof
#172METHODS FOR PRODUCING SALMONELLA O-ANTIGEN CAPSULES, COMPOSITIONS AND USES THEREOF
#173Compositions and methods for diagnosing, preventing and treating and infection
#174AN ISOLATED IMMUNOGENIC BACTERIAL ANTIGEN AND ITS USE IN THE PREVENTION AND TREATMENT OF INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA
#175Protein matrix vaccines and related methods of making and administering such vaccines
#176Polysaccharide-protein conjugate vaccines
#177Compositions and methods of enhancing immune responses
#178Flagellin related polypeptides and uses thereof
#179Compositions and methods of enhancing immune responses to enteric pathogens
#180Compositions produced using enteric pathogens and methods of use
#181Flagellin related polypeptides and uses thereof
#182DUAL ADJUVANT VACCINE COMPOSITIONS, PREPARATION AND USES
#183Synthetic Peptides as Carriers for Conjugation with Polysaccharides
#184Tissue targeted antigenic activation of the immune response to treat cancers
#185Immune modulator for immunotherapy and vaccine formulation
#186Preparation of live vaccines
#187Vitro assays for detecting
#188Cross-protecting vaccines
#189Multifunctional oral vaccine based on chromosome recombineering
#190USE OF THE SALMONELLA SPP TYPE III SECRETION PROTEINS AS A PROTECTIVE VACCINATION
#191Flagellin related polypeptides and uses thereof
#192PURIFICATION OF BACTERIAL VESICLES
#193Saccharide Conjugate Vaccines
#194DNA vaccine for use in pancreatic cancer patients
#195Deletion mutants of flagellin and methods of use
#196Deletion mutants of flagellin and methods of use
#197LPS vaccine
#198NOVEL METHOD FOR THE PREPARATION OF A STRAIN-ADAPTED VACCINE
#199Methods of stimulating protective immunity employing Dengue viral antigens
#200Attenuated live bacteria with increased acid resistance and methods of use thereof
#201Immunogenic compositions comprising
#202CONJUGATION OF BIOMOLECULES USING DIELS-ALDER CYCLOADDITION
#203Methods for making saccharide-protein glycoconjugates
#204SYNTHETIC DERIVATIVES OF MPL AND USES THEREOF
#205Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
#206Bacterial challenge model in cattle using a trans- and intra-dermal route to infect peripheral lymph nodes
#207Use of Toll-Like Receptor agonist for treating cancer
#208Vaccine composition capable of inducing memory antibody response from single point immunization
#209Spray dried compositions and methods of use
#210Prevention of recrudescense
#211Compositions and methods of enhancing immune responses
#212Protein matrix vaccine compositions including polycations
#213Immunogenic composition for immune system modulation and use thereof, method for treating and preventing diseases, method for inducing cell regeneration and method for restoring immune response
#214Methods of stimulating protective immunity employing Dengue viral antigens
#215Vaccine injection, preparation method and use thereof
#216Recombinant bacterium comprising a toxin/antitoxin system
#217Immunogenic Affinity-Conjugated Antigen Systems Based on Papaya Mosaic Virus and Uses Thereof
#218Methods for detecting antibody that specifically bind a siderophore receptor polypeptide
#219Avirulent variants and pharmaceutical composition using the same
#220Use of flagellins from the genus as vaccination adjuvants
#221Personalized site-specific immunomodulation
#222Conjugated Vi saccharides
#223Broad spectrum vaccine against typhoidal and non-typhoidal disease
#224Campylobacter polypeptides and methods of use
#225vaccine
#226Avirulent variants and pharmaceutical composition using the same
#227PURIFICATION OF BACTERIAL VESICLES
#228Bacterium comprising a regulated nucleic acid
#229Avirulent variants and pharmaceutical composition using the same
#230Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
#231Immunogenic anti-inflammatory compositions
#232PROTEIN MATRIX VACCINES OF IMPROVED IMMUNOGENICITY
#233Immunizing Compositions and Methods of Use
#234Immunizing compositions and methods of use
#235Gene expressing a bifidobacterium surface-presented fusion protein
#236Strain of s. typhimurium, its use and a method to obtain a therapeutic vaccine vector
#237Attenuated FNR deficient enterobacteria
#238Sticky soft gel for treating poultry
#239SALMONELLA MARKER VACCINE
#240presenting N-glycan or derivatives thereof
#241Recombinant bacterium and methods of antigen and nucleic acid delivery
#242Polysaccharide-protein conjugate vaccines
#243Attenuated serovar paratyphi A and uses thereof
#244Compositions Produced Using Enteric Pathogens and Methods of Use
#245Flagellin related polypeptides and uses thereof
#246Flagellin related polypeptides and uses thereof
#247Oral vaccine
#248Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
#249SALMONELLA MARKER VACCINE
#250Broad spectrum vaccine against non-typhoidal
#251vectored vaccines against and methods of use
#252Method for producing multiple modifications in the chromosome of gram-negative bacteria and salmonella strains which are deficient in c-di-GMP synthesis obtained by said method
#253Recombinant bacterium capable of eliciting a protective immune response against
#254Methods and Compositions for Stabilization of a Virus Vaccine
#255Immunizing compositions and methods of use
#256Multivalent Vaccines Based on Papaya Mosaic Virus and Uses Thereof
#257NON-TYPHOIDAL SALMONELLA VACCINES
#258Immunizing compositions and methods of use
#259Immunizing compositions and methods of use
#260Tissue targeted antigenic activation of the immune response to treat cancers
#261Live attenuated aldolase-negative bacterial vaccine
#262Compositions Comprising Salmonella Porins and Uses Thereof as Adjuvants and Vaccines
#263Compositions and methods of enhancing immune responses to flagellated bacterium
#264CONJUGATED VI SACCHARIDES
#265Deletion mutants of flagellin and methods of use
#266Mutated strain and use thereof in a vaccine
#267MALVA MOSAIC VIRUS AND VIRUS-LIKE PARTICLES AND USES THEREOF
#268Formulation for room temperature stabilization of a live attenuated bacterial vaccine
#269LIVE ATTENUATED SALMONELLA VACCINE
#270Recombinant bacterium capable of eliciting an immune response against enteric pathogens
#271Apparatus and method for dehydrating biological materials
#272Compositions and methods of enhancing immune responses
#273PROCESS FOR TREATMENT OF RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS
#274Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
#275Vaccine compositions and methods of use to protect against infectious disease
#276LIVE ATTENUATED SALMONELLA FOR USE AS VACCINE
#277SECRETION-RELATED BACTERIAL PROTEINS FOR NLRC4 STIMULATION
#278PAPAYA MOSAIC VIRUS-BASED VACCINES AGAINST SALMONELLA TYPHI AND OTHER ENTEROBACTERIAL PATHOGENS
#279Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals
#280LIVE ATTENUATED SALMONELLA VACCINE
#281Attenuated FNR deficient enterobacteria
#282Composition and method for controlling intestinal pathogenic organisms
#283Method of immunizing humans against using a Vi-EPA conjugate vaccine
#284Conjugate purification
#285METHODS OF REDUCING PORCINE CIRCOVIRUS-ASSOCIATED DISEASE OUTBREAKS
#286Compositions produced using enteric pathogens and methods of use
#287PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS
#288Immunogenic Affinity-Conjugated Antigen Systems Based on Papaya Mosaic Virus and Uses Thereof
#289Chemically defined vaccine stabiliser
#290Live attenuated aldolase-negative bacterial vaccine
#291VACCINE
#292Method for vaccination of poultry by bacteriophage lysate bacterin
#293NON-TOXIC MUTANTS OF PATHOGENIC GRAM-NEGATIVE BACTERIA
#294Live attenuated bacterial vaccine
#295VACCINE DEVELOPMENT STRATEGY USING MICROGRAVITY CONDITIONS
#296Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
#297Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
#298strains of reduced pathogenicity, method for their preparation and uses thereof
#299Immunizing compositions and methods of use
#300ACTIVE IMMUNIZATION USING A SIDEROPHORE RECEPTOR PROTEIN